rs146031219
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001127208.3(TET2):c.521C>A(p.Pro174His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,613,938 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_001127208.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TET2 | NM_001127208.3 | c.521C>A | p.Pro174His | missense_variant | 3/11 | ENST00000380013.9 | NP_001120680.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00136 AC: 207AN: 152096Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00154 AC: 386AN: 250054Hom.: 2 AF XY: 0.00144 AC XY: 195AN XY: 135246
GnomAD4 exome AF: 0.00121 AC: 1774AN: 1461724Hom.: 5 Cov.: 34 AF XY: 0.00118 AC XY: 857AN XY: 727164
GnomAD4 genome AF: 0.00136 AC: 207AN: 152214Hom.: 1 Cov.: 32 AF XY: 0.00133 AC XY: 99AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 06, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | TET2: BP4, BS2 - |
TET2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 20, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at